TotalMarketCap

Royalty Pharma

RPRXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$38.862 B

$67.75 +0.28%

Close of 6 Nov 2026

As of 6 Nov 2026, Royalty Pharma (RPRX) has a market capitalization of $38.9B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.38B

#1040 by revenue

Earnings

$770.9M

#471 by earnings

Shares outstanding

448,610,000

Latest filing cover page

P/E ratio

50.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #16Teva Pharmaceutical IndustriesTEVA$48.7B
  2. #17BeOne MedicinesONC$44.0B
  3. #18Royalty PharmaRPRX$38.9B
  4. #19ZoetisZTS$33.9B
  5. #20Genmab A/SGMAB$33.0B

What if Royalty Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$49,227.01

Per share 727× higher

Bitcoin $1.53T

$2,663.59

Per share 39.3× higher

Apple $5.02T

$8,744.31

Per share 129× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for Royalty Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.